EDGAR Filing Documents for 0001193125-22-078944

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-22-078944

Filing Date

2022-03-18

Accepted

2022-03-18 07:57:38

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d258857ds3.htm	S-3	417942
2	EX-1.2	d258857dex12.htm	EX-1.2	186293
3	EX-4.3	d258857dex43.htm	EX-4.3	346038
4	EX-4.4	d258857dex44.htm	EX-4.4	339422
5	EX-4.5	d258857dex45.htm	EX-4.5	34434
6	EX-4.6	d258857dex46.htm	EX-4.6	34839
7	EX-5.1	d258857dex51.htm	EX-5.1	35609
8	EX-23.1	d258857dex231.htm	EX-23.1	1674
9	EX-FILING FEES	d258857dexfilingfees.htm	EX-FILING FEES	56652
10	GRAPHIC	g258857dsp00138.jpg	GRAPHIC	14821
11	GRAPHIC	g258857dsp138.jpg	GRAPHIC	2337
12	GRAPHIC	g258857g04a42.jpg	GRAPHIC	45990
	Complete submission text file	0001193125-22-078944.txt		1536681

Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215

Business Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215 617-370-8701

Decibel Therapeutics, Inc. (Filer) CIK: 0001656536 (see all company filings)